0001127602-23-006508.txt : 20230222
0001127602-23-006508.hdr.sgml : 20230222
20230222165447
ACCESSION NUMBER: 0001127602-23-006508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230218
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hykes Andrew
CENTRAL INDEX KEY: 0001806431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 23654180
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER AVENUE, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-02-18
0001531048
Inari Medical, Inc.
NARI
0001806431
Hykes Andrew
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
1
President and CEO
Common Stock
2023-02-18
4
A
0
46549
0
A
139595
D
Common Stock
2023-02-21
4
S
0
9000
55.19
D
130595
D
Common Stock
1550
I
By Child 1
Common Stock
1550
I
By Child 2
Common Stock
1550
I
By Child 3
Common Stock
1000
I
By Spouse
Stock Options (Right to Buy)
56.00
2023-02-18
4
A
0
36085
56.00
A
2030-02-17
Common Stock
36085
36085
D
2023 Annual Restricted Stock Units grant ("RSUs"). Vesting Commencement Date begins January 1, 2023, 1/16th of the RSUs shall vest on each quarterly anniversary of the vesting Commencement Date.
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
This transaction was executed in multiple trades at prices ranging from $55.00 to $55.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These options were granted on February 18, 2023 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2023.
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
2023-02-22